跳至主要内容
临床试验/NCT02753985
NCT02753985已完成不适用

Adherence to Aromatase Inhibitors: The Role of Partners

Abramson Cancer Center at Penn Medicine1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2014年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Number of Surveys Completed

研究概览

简要总结

This is a qualitative study which explores the role that partners play in breast cancer survivors adherence to aromatase inhibitors and management of their side effects. Both patients and their partners will be interviewed (separately) in order to capture multiple perspectives. The target number of subjects is 64 (32 patients and 32 partners). The primary method of data collection will be face-to-face semi-structured interviews. These interviews will be audio-recorded.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women and partners of women with stage I-III breast cancer who
  • have completed primary cancer treatments (surgery, chemotherapy, radiotherapy)
  • have experienced AI side effects
  • live with a romantic partner.

排除标准

  • 未提供

结局指标

主要结局

Number of Surveys Completed

时间窗: 2 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验